Gene therapy for articular cartilage repair

Abstract Articular cartilage serves as the gliding surface of joints. It is susceptible to damage from trauma and from degenerative diseases. Restoration of damaged articular cartilage may be achievable through the use of cell-regulatory molecules that augment the reparative activities of the cells, inhibit the cells' degradative activities, or both. A variety of such molecules have been identified. These include insulin-like growth factor I, fibroblast growth factor 2, bone morphogenetic proteins 2, 4, and 7, and interleukin-1 receptor antagonist. It is now possible to transfer the genes encoding such molecules into articular cartilage and synovial lining cells. Although preliminary, data from in-vitro and in-vivo studies suggest that gene therapy can deliver such potentially therapeutic agents to protect existing cartilage and to build new cartilage.

[1]  A. Herington,et al.  Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. , 1986, The Biochemical journal.

[2]  C. Hidaka,et al.  Enhanced matrix synthesis and in vitro formation of cartilage‐like tissue by genetically modified chondrocytes expressing BMP‐7 , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  J. Pelletier,et al.  In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. , 1997, Arthritis and rheumatism.

[4]  Y. Hirasawa,et al.  Adenovirus mediated gene delivery to the joints of guinea pigs. , 1998, The Journal of rheumatology.

[5]  H. Mizukami,et al.  Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. , 2005, Arthritis and rheumatism.

[6]  C. McIlwraith,et al.  Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene , 2002, Gene Therapy.

[7]  J. Mason,et al.  Stem Cells as Platforms for Delivery of Genes to Enhance Cartilage Repair , 2003, The Journal of bone and joint surgery. American volume.

[8]  E. Schwarz,et al.  In vivo gene delivery to articular chondrocytes mediated by an adeno‐associated virus vector , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  S. Stover,et al.  Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1. , 1992, American journal of veterinary research.

[10]  A. Grodzinsky,et al.  Transport and binding of insulin-like growth factor I through articular cartilage. , 2003, Archives of biochemistry and biophysics.

[11]  W. B. van den Berg,et al.  Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. , 2003, Arthritis and rheumatism.

[12]  U. Dettweiler,et al.  Points to consider for ethics committees in human gene therapy trials. , 2001, Bioethics.

[13]  Albert C. Chen,et al.  Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. , 1994, Archives of biochemistry and biophysics.

[14]  P. Robbins,et al.  Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. , 2000, Arthritis and rheumatism.

[15]  R. Sellers,et al.  Repair of Articular Cartilage Defects One Year After Treatment with Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)* , 2000, The Journal of bone and joint surgery. American volume.

[16]  D. Duan,et al.  A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation , 2000, Nature Medicine.

[17]  Y. Hirasawa,et al.  Ex vivo gene delivery using an adenovirus vector in treatment for cartilage defects. , 2000, The Journal of rheumatology.

[18]  G. Vunjak‐Novakovic,et al.  Gene transfer of a human insulin-like growth factor I cDNA enhances tissue engineering of cartilage. , 2002, Human gene therapy.

[19]  G. Bandara,et al.  Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Mizukami,et al.  Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. , 2005, Human gene therapy.

[21]  Lars Engebretsen,et al.  Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. , 2004, The Journal of bone and joint surgery. American volume.

[22]  H. Hsu,et al.  Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis. , 2000, Human gene therapy.

[23]  E. Terwilliger,et al.  Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. , 2003, Human gene therapy.

[24]  Simon C Watkins,et al.  Gene transfer to human joints: progress toward a gene therapy of arthritis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Robbins,et al.  Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy , 2005, Gene Therapy.

[26]  D. Zurakowski,et al.  Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF‐2) in vivo , 2006, The journal of gene medicine.

[27]  K Remberger,et al.  Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I) , 2005, Gene Therapy.

[28]  J. Buckwalter,et al.  Restoration of the osteoarthrotic joint. , 1996, The Journal of bone and joint surgery. American volume.

[29]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[30]  K. Marshall,et al.  Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. , 1998, Osteoarthritis and cartilage.

[31]  T. Aigner,et al.  Autologous Chondrocyte Implantation and Osteochondral Cylinder Transplantation in Cartilage Repair of the Knee Joint: A Prospective, Comparative Trial , 2003, The Journal of bone and joint surgery. American volume.

[32]  J. Bonadio,et al.  Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. , 1995, The Journal of clinical investigation.

[33]  Peter Müller,et al.  Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture , 1977, Nature.

[34]  E. Stankevičius,et al.  A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. , 2005, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[35]  R. Warren,et al.  Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein‐7 , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[36]  C. Pilapil,et al.  In vivo gene delivery to synovium by lentiviral vectors. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  P. Robbins,et al.  Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[38]  T. Aigner,et al.  Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. , 2001, Arthritis and rheumatism.

[39]  D. Duan,et al.  Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Sheppard,et al.  In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. , 1999, The American journal of pathology.

[41]  Xiao‐Kang Li,et al.  Long-term Gene Expression Using the Lentiviral Vector in Rat Chondrocytes , 2005, Clinical orthopaedics and related research.

[42]  P. Robbins,et al.  Insulinlike Growth Factor-I Gene Therapy Applications for Cartilage Repair , 2000, Clinical orthopaedics and related research.

[43]  D. Zurakowski,et al.  Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  D. Zurakowski,et al.  Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation , 2001, Gene Therapy.

[45]  Xiaoling Zhang,et al.  Suppression of early experimental osteoarthritis by gene transfer of interleukin‐1 receptor antagonist and interleukin‐10 , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[46]  S. Kim,et al.  Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor beta 1-producing fibroblasts. , 2001, Human gene therapy.

[47]  D. Kohn,et al.  Menisci are Efficiently Transduced by Recombinant Adeno-Associated virus Vectors in Vitro and in Vivo , 2004, The American journal of sports medicine.

[48]  B. Davidson,et al.  Adenoviral-mediated gene transfer to rabbit synovium in vivo. , 1993, The Journal of clinical investigation.

[49]  T. Ueno,et al.  Confocal laser microscopy of chondrocytes that received gene transfer using in vitro electroporation. , 2002, The Kurume medical journal.

[50]  P. Robbins,et al.  Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. , 1997, Osteoarthritis and cartilage.

[51]  G. Boivin,et al.  Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  Ying Li,et al.  Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. , 2005, Osteoarthritis and cartilage.

[53]  P. Robbins,et al.  Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function. , 2001, Human gene therapy.

[54]  D. Zurakowski,et al.  Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation , 2004, The journal of gene medicine.

[55]  G. Bentley,et al.  A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. , 2003, The Journal of bone and joint surgery. British volume.

[56]  A. Grodzinsky,et al.  Transport of tissue inhibitor of metalloproteinases‐1 through cartilage: Contributions of fluid flow and electrical migration , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[57]  Freddie H Fu,et al.  Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. , 2006, Arthritis and rheumatism.

[58]  P. Benya,et al.  Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture , 1978, Cell.

[59]  R. Coutts,et al.  Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*† , 1996 .

[60]  G. Kollias,et al.  Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. , 2000, The Journal of rheumatology.

[61]  Y. Tsao,et al.  Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. , 2000, Arthritis and rheumatism.

[62]  G. Balian,et al.  Marrow stromal cells embedded in alginate for repair of osteochondral defects. , 2000, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[63]  E. Lechman,et al.  Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. , 2000, Arthritis and rheumatism.

[64]  R. Hewick,et al.  Recombinant human bone morphogenetic protein‐2 maintains the articular chondrocyte phenotype in long‐term culture , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[65]  M. Menger,et al.  Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid‐mediated gene transfer in a gel suspension delivery system , 2003, The journal of gene medicine.

[66]  H. Madry,et al.  Efficient lipid-mediated gene transfer to articular chondrocytes , 2000, Gene Therapy.

[67]  Ying Li,et al.  Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. , 2004, Tissue engineering.